American simulation software and consulting company at Lancaster in California, founded in 1996 and listed on Nasdaq. Develops modelling software for drug discovery and development including GastroPlus for physiologically based pharmacokinetics and absorption, ADMET Predictor for property prediction, MonolixSuite and PKPlus for population pharmacokinetic modelling and DILIsym for drug induced liver injury simulation, and provides model informed drug development, regulatory writing and medical communications consulting through its Cognigen, Lixoft, Immunetrics and Pro-ficiency businesses.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen